Exodus Point Capital Management, LP Forte Biosciences, Inc. Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$31.5 - $42.5 $1.42 Million - $1.91 Million
-45,019 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$25.01 - $40.24 $380,126 - $611,607
15,199 Added 50.97%
45,019 $1.54 Million
Q4 2020

Feb 16, 2021
BUY
$28.66 - $46.79 $854,641 - $1.4 Million
29,820 New
29,820 $1.09 Million

Others Institutions Holding FBRX

# of Institutions
29
Shares Held
17.3M
Call Options Held
3.1K
Put Options Held
0
View Full List

About Forte Biosciences, Inc.

FBRX Quotes by TradingView
  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $106M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email